Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Nov 21, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, nothing major to see here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 21, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This filing serves as a standard notification to the SEC for foreign private issuers, indicating ongoing compliance and reporting obligations.
Risk Assessment
Risk Level: low — The filing is a routine report and does not contain any new material information that would impact the company's risk profile.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001135951 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification
- 03 Life Sciences (company) — Organization Name
- 001-15182 (company) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on November 21, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Does this filing contain any specific financial results or material events?
Based on the provided text, this filing appears to be a routine report and does not detail specific financial results or material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-21 06:06:45
Filing Documents
- drr0697_6k.htm (6-K) — 14KB
- drr0697_ex99-1.htm (EX-99.1) — 8KB
- drr0697_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0697_ex99-1img02.jpg (GRAPHIC) — 3KB
- 0001575872-24-001198.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 20, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3